Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring
2015 · Cancer and Metastasis Reviews · 338 citations
https://doi.org/10.1007/s10555-015-9551-7
A
Andrew McGuire
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
19
Papers
888
Citations
8
h-index
8
i10-index
Andrew McGuire is an academic researcher from Infectious Disease Research Institute. The author has contributed to research in topics: Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research & MicroRNA in disease regulation. The author has an h-index of 8, co-authored 17 publications.
ORCID: 0000-0002-9474-737XPapers by this author
worksQuantifying Argonaute 2 (Ago2) expression to stratify breast cancer
2019 · BMC Cancer · 35 citations
https://doi.org/10.1186/s12885-019-5884-x
Healthcare costs and health outcomes analysis of neoadjuvant Trastuzumab therapy for human epidermal growth factor receptor 2 (HER2) positive breast cancer
2025 · Cancer Pathogenesis and Therapy · 0 citations
https://doi.org/10.1016/j.cpt.2025.08.006
Isolation and characterization of broadly-neutralizing anti-HCMV-gB antibodies from human donors using a prefusion-stabilized HCMV gB variant
2026 · PLoS Pathogens · 0 citations
https://doi.org/10.1371/journal.ppat.1013950
Transgenic mouse-derived human monoclonal antibodies targeting EBV gp350 and gp42 provide basis for therapeutic development
2026 · Cell Reports Medicine · 0 citations
https://doi.org/10.1016/j.xcrm.2026.102618
BPS2026 – Optimizing cryo-EM sample preparation for HCMV gB-antibody complexes
2026 · Biophysical Journal · 0 citations
https://doi.org/10.1016/j.bpj.2025.11.1051
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat